cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Inhibrx Inc
3 own
3 watching
Current Price
$38.1
$0.42
(1.11%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
1,172.17M
52-Week High
52-Week High
39.50000
52-Week Low
52-Week Low
14.30500
Average Volume
Average Volume
0.31M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization1,172.17M
icon52-Week High39.50000
icon52-Week Low14.30500
iconAverage Volume0.31M
iconDividend Yield--
iconP/E Ratio--
What does the Inhibrx Inc do?
Inhibrx, Inc., a clinical-stage biotechnology company, focuses on developing a pipeline of novel biologic therapeutic candidates. The company s therapeutic candidates include INBRX-109, a tetravalent agonist of death receptor 5, which is in Phase 2 clinical trials to treat cancers, such as chondrosarcoma, mesothelioma, and pancreatic adenocarcinoma; INBRX-105, a tetravalent conditional agonist of programmed death-ligand 1 and a conditional agonist of 4-1BB that is in Phase 1 clinical trials to treat patients with locally advanced or metastatic solid tumors; and INBRX-101, an alpha-1 antitrypsin (AAT)-Fc fusion protein therapeutic candidate, which is in Phase 1 clinical trials for use in the treatment of patients with AAT deficiency. It also provides INBRX-106, a hexavalent agonist of OX40 for a range of oncology indications. The company was founded in 2010 and is headquartered in La Jolla, California.
Read More
How much money does Inhibrx Inc make?
News & Events about Inhibrx Inc.
PR Newswire
10 months ago
Inhibrx Initiates a Registration-Enabling Trial of INBRX-101 in AATD and Announces Lift of Partial Clinical Hold on INBRX-109 DR5 Agonist Trials Inhibrx Initiates a Registration-Enabling Trial of INBRX-101 in AATD and Announces Lift of Partial Clinical Hold on INBRX-109 DR5 Agonist Trials PR...
Zolmax
11 months ago
Inhibrx, Inc. (NASDAQ:INBX Get Rating) Analysts at Jefferies Financial Group issued their FY2024 earnings per share estimates for Inhibrx in a research report issued to clients and investors on Monday, March 6th. Jefferies Financial Group analyst M. Yee expects that the company will earn ($3.55) per...
Ticker Report
1 year ago
Inhibrx, Inc. (NASDAQ:INBX Get Rating) insider Brendan P. Eckelman sold 28,750 shares of the businesss stock in a transaction dated Wednesday, February 1st. The shares were sold at an average price of $24.73, for a total value of $710,987.50. Following the completion of the sale, the ...
Zolmax
1 year ago
Inhibrx, Inc. (NASDAQ:INBX Get Rating) CEO Mark Lappe sold 21,665 shares of the firms stock in a transaction dated Monday, January 23rd. The stock was sold at an average price of $25.36, for a total transaction of $549,424.40. Following the completion of the sale, the chief executive officer now ...
Ticker Report
1 year ago
Inhibrx, Inc. (NASDAQ:INBX Get Rating) CEO Mark Lappe sold 21,665 shares of Inhibrx stock in a transaction that occurred on Monday, January 23rd. The stock was sold at an average price of $25.36, for a total transaction of $549,424.40. Following the completion of the transaction, the chief ...
Frequently Asked Questions
Frequently Asked Questions
What is Inhibrx Inc share price today?
plus_minus_icon
Can Indians buy Inhibrx Inc shares?
plus_minus_icon
How can I buy Inhibrx Inc shares from India?
plus_minus_icon
Can Fractional shares of Inhibrx Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Inhibrx Inc stocks?
plus_minus_icon
What is today’s traded volume of Inhibrx Inc?
plus_minus_icon
What is today’s market capitalisation of Inhibrx Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Inhibrx Inc?
plus_minus_icon
What percentage is Inhibrx Inc down from its 52-Week High?
plus_minus_icon
What percentage is Inhibrx Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$38.1
$0.42
(1.11%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00